News | July 29, 2023
AiMeD expresses dismay over FICCI’s ‘Un-Make in India’ drive
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Subscribe To Our Newsletter & Stay Updated
